Orthofix International N.V. (OFIX) vs. DENTSPLY SIRONA (XRAY) Critical Review
Orthofix International N.V. (NASDAQ: OFIX) and DENTSPLY SIRONA (NASDAQ:XRAY) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst recommendations and profitability.
This is a summary of recent recommendations for Orthofix International N.V. and DENTSPLY SIRONA, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Orthofix International N.V.||0||0||5||0||3.00|
Orthofix International N.V. presently has a consensus target price of $52.50, suggesting a potential upside of 6.97%. DENTSPLY SIRONA has a consensus target price of $66.00, suggesting a potential upside of 15.14%. Given DENTSPLY SIRONA’s higher probable upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Orthofix International N.V..
Institutional and Insider Ownership
94.4% of Orthofix International N.V. shares are held by institutional investors. Comparatively, 93.9% of DENTSPLY SIRONA shares are held by institutional investors. 5.6% of Orthofix International N.V. shares are held by company insiders. Comparatively, 2.0% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Orthofix International N.V. and DENTSPLY SIRONA’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Orthofix International N.V.||$418.71 million||2.13||$45.74 million||$0.42||116.86|
|DENTSPLY SIRONA||$3.84 billion||3.43||$823.80 million||($3.47)||-16.52|
DENTSPLY SIRONA has higher revenue and earnings than Orthofix International N.V.. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Orthofix International N.V., indicating that it is currently the more affordable of the two stocks.
DENTSPLY SIRONA pays an annual dividend of $0.35 per share and has a dividend yield of 0.6%. Orthofix International N.V. does not pay a dividend. DENTSPLY SIRONA pays out -10.1% of its earnings in the form of a dividend.
Risk & Volatility
Orthofix International N.V. has a beta of 0.2, meaning that its share price is 80% less volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500.
This table compares Orthofix International N.V. and DENTSPLY SIRONA’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Orthofix International N.V.||1.88%||9.96%||7.32%|
Orthofix International N.V. Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.